Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.6.3 to the page, indicating the latest version of the content. The prior Revision: v3.6.2 was removed, suggesting an update to the page's revision history rather than substantive changes.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision label in the page footer changed from v3.6.0 to v3.6.2, indicating a new version of the page. This is a minor update to page metadata rather than changes to the study content or results.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays 'No longer looking for participants,' signaling recruitment for this study is closed. In addition, several navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was updated, with the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a new release of the page or its underlying system. This reflects backend/documentation changes rather than substantive changes to the study information.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a new revision label 'Revision: v3.5.4' and removed the previous label 'Revision: v3.5.3', indicating a minor update to the page's release metadata.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s revision version was updated from **v3.5.0** to **v3.5.3**, indicating a minor platform/content delivery update rather than a change to the trial record itself.SummaryDifference0.0%

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.